BYHEALTH CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.12 CNY | -.--% |
|
-0.53% | -11.22% |
| Apr. 25 | Byhealth Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 12 | Byhealth Co., Ltd Approves Cash Dividend for the Year 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Byhealth Co Ltd is a China-based company mainly engaged in the research, development, production and sales of dietary nutritional supplements. The Company's main products include glucosamine chondroitin vitamin D calcium tablets, natto red yeast and ginkgo leaf capsules, pueraria curcuma collagen tablets, donkey-hide gelatin angelica astragalus tablets, fish oil soft capsules, glucosamine chondroitin sulfate collagen peptide tablets and glucosamine chondroitin sulfate calcium tablets. The Company's main product categories include immune-boosting products, women's health products, bone health products and vitamins. The Company's products are mainly sold online and offline through brands such as By-Health, Jianliduo and Lifespace. The Company mainly conducts its businesses in domestic and overseas markets.
Sector
Food Processing
Calendar
2024-08-04
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
15.12
CNY
Average target price
22.19
CNY
Spread / Average Target
+46.77%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.22% | 3.55B | |
| +11.85% | 8.05B | |
| +5.29% | 7.59B | |
| +2.63% | 6.07B | |
| -2.80% | 3.85B | |
| -7.04% | 1.28B | |
| -32.50% | 1.03B | |
| +12.52% | 971M | |
| -11.19% | 907M | |
| -15.69% | 813M |
- Stock Market
- Equities
- 300146 Stock
- News Byhealth Co., Ltd
- BY-Health Sees Up to 30% Profit Slump in 2022
